ATI RN Pharmacology Proctored Exam Test Bank – All Versions (2025–2027) | Latest Verified Questions & Answers

ATI Pharmacology Proctored exam Test Bank-
comprehensive

1. i1) iA inurse iis icaring ifor ia iclient iwith 3. Calcitonin (Miacalcin)
i i


hyperparathyroidism and notes that the
i i i i i Rationale:
i



client's serum calcium level is 13 mg/dL.
i i i i i i i The normal serum calcium level is 8.6 to 10.0 mg/dL. This client is experiencing
i i i i i i i i i i i i i


Which medication should the nurse prepare to
i i i i i i i hypercalcemia.Calciumgluconateandcalciumchloridearemedicationsusedforthe
i i i i i


administer as prescribed to the client?
i i i i i i treatment of tetany, which occurs as a result of acute hypocalcemia. In
i i i i i i i i i i i i


1. Calcium chloride i hypercalcemia,largedosesofvitaminDneedtobeavoided.Calcitonin,athyroid
i i i i i i i i i i i i i



2. Calcium gluconate i hormone, decreases the plasma calcium level by inhibiting bone resorption and
i i i i i i i i i i i



3. Calcitonin (Miacalcin) i lowering the serum calciumconcentration.
i i i i i



4. Large doses of vitamin D i i i i




2. i2.)iOral iiron isupplements iare iprescribed ifor ia 4. Orange juice
i i



6-year-old child with iron deficiency
i i i i i Rationale:
i



anemia. The nurse instructs the mother to
i i i i i i i Vitamin C increases the absorption of iron by the body. The mother should be
i i i i i i i i i i i i i



administer the iron with which best food
i i i i i i i instructedtoadministerthemedicationwithacitrusfruitorajuicethatishighin
i i i i i i i i i i i i i i i i



item?
i vitaminC.Milkmayaffectabsorptionoftheiron.Waterwillnotassistinabsorption.
i i i i i i i i i i i



1. Milk Orangejuicecontains a greateramountofvitamin C thanapplejuice.
i i i i i i i i i i i i



2. Water
3. Apple juice i



4. Orange juice i




3. i3.) iSalicylic iacid iis iprescribed ifor ia iclient 1. Tinnitus
i



with a diagnosis of psoriasis. The nurse
i i i i i i i Rationale:
i



monitors the client, knowing that which of
i i i i i i i Salicylic acid is absorbed readily through the skin, and systemic toxicity (salicylism)
i i i i i i i i i i i



thefollowingwouldindicatethepresence
i i i i i i canresult.Symptomsincludetinnitus,dizziness,hyperpnea,andpsychological
i i i i i i i i i



of systemic toxicity from this medication?
i i i i i i disturbances. Constipationand diarrhea arenotassociated with salicylism.
i i i i i i i i i



1. Tinnitus
2. Diarrhea
3. Constipation
4. Decreased respirations i




4. i4.) iThe icamp inurse iasks ithe ichildren 4. At least 30 minutes beforeexposure to the sun
i i i i i i i i



preparing to swim in the lake if they have
i i i i i i i i i Rationale:
i



applied sunscreen. The nurse reminds the
i i i i i i Sunscreens are most effective when applied at least 30 minutes beforeexposure to the
i i i i i i i i i i i i



children that chemical sunscreens are most
i i i i i i sun so that they can penetrate the skin. All sunscreens should be reapplied after
i i i i i i i i i i i i i i



effective when applied:
i i i swimming or sweating.
i i i



1. Immediately before swimming i i



2. 15 minutes before exposure to the sun
i i i i i i



3. Immediately before exposure to the sun i i i i i



4. At least 30 minutes before exposure to
i i i i i i


the sun
i i




5. i5.) iMafenide iacetate i(Sulfamylon) iis 3. Informing theclient that this is normal i i i i i i



prescribed for the client with a burn injury.
i i i i i i i i Rationale:
i



When applying the medication, the client
i i i i i i Mafenideacetateis bacteriostatic forgram-negativeandgram-positive organisms i i i



complains of local discomfort and burning.
i i i i i i andisusedtotreatburnstoreducebacteriapresentinavasculartissues.Theclient
i i i i i i i i i i i i i



Which of the following is the most
i i i i i i i shouldbeinformedthatthemedicationwillcauselocaldiscomfortandburningand
i i i i i i i i i i i i



appropriate nursing action?
i i i thatthisisanormalreaction;thereforeoptions 1, 2,and4areincorrect
i i i i i i i i i i i i i i



1. Notifying the registered nurse i i i



2. Discontinuing the medication i i



3. Informing the client that this is normal i i i i i i



4. Applying a thinner film than prescribed i i i i i


to the burn site
i i i i

, 1. Hyperventilation
6. i6.) iThe iburn iclient iis ireceiving itreatments iof

topical mafenide acetate(Sulfamylon) tothe
i i i i
Rationale:
i




site of injury. The nurse monitors the client,
i i i i i i i i
Mafenideacetateisacarbonicanhydraseinhibitorandcansuppressrenalexcretion of i i i i i i i i i




knowing that which of the following indicates
i i i i i i i
acid, thereby causing acidosis. Clients receiving this treatment should be
i i i i i i i i i i




that a systemic effect has occurred?
i i i i i i
monitored for signs of an acid-base imbalance (hyperventilation). If this occurs, the
i i i i i i i i i i i i




1. Hyperventilation
medicationshouldbediscontinuedfor1to2days.Options3and4describelocal
i i i i i i i i i i i i i i i


ratherthansystemiceffects.Anelevatedbloodpressuremaybeexpectedfromthe pain
2. Elevated blood pressure
i i i i i i i i i i i i i i
i i

that occurs with a burn injury.
3. Local pain at the burn site
i i i i i i
i i i i i



4. Local rash at the burn site i i i i i



2. Triglyceride level
7. i7.) iIsotretinoin iis iprescribed ifor iaiclient iwith
i



Rationale:
severe acne. Before the administration of this
i
i i i i i i i

Isotretinoincanelevatetriglyceridelevels.Bloodtriglyceridelevelsshouldbe
medication, the nurse anticipates that which
i i i i i i i i i
i i i i i i

measured before treatment and periodically thereafter until the effect on the
laboratory test will be prescribed?
i i i i i i i i i i i
i i i i i


1. Platelet count i
triglycerideshasbeenevaluated.Options1,3,and4donotneedtobemonitored
i i i i i i i i i i i i i i i



specifically during this treatment.
2. Triglyceride level
i i i i
i


3. Complete blood count i i



4. White blood cell count i i i



1. Vitamin A
8. i8.) iA iclient iwith isevere iacne iis iseen iin ithe
i


Rationale:
clinic and the health care provider (HCP)
i
i i i i i i i

Isotretinoinis ametabolite of vitamin Aand canproducegeneralizedintensification
prescribes isotretinoin. The nurse reviews the
i i i i i
i i i i i i

of isotretinoin toxicity. Because of the potential for increased toxicity, vitamin A
client's medication record and would contact
i i i i i i i i i i i i
i i i i i i

supplementsshould be discontinuedbeforeisotretinointherapy.Options 2, 3, and 4
the (HCP) if the client is taking which
i i i i i i i
i i i i i i i i

arenot contraindicated with theuse of isotretinoin.
medication?
i i i i i i i i
i


1. Vitamin A i



2. Digoxin (Lanoxin) i



3. Furosemide (Lasix) i



4. Phenytoin (Dilantin) i


2. Axilla
9. i9.) iThe inurse iis iapplying ia itopical
Rationale:
corticosteroid to a client with eczema. The
i
i i i i i i i

Topicalcorticosteroidscanbeabsorbedintothesystemiccirculation.Absorptionis
nurse would monitor for the potential for
i i i i i i i i
i i i i i i i

higher from regions where the skin is especially permeable (scalp, axilla, face,
increased systemic absorption of the
i i i i i i i i i i i i
i i i i i

eyelids, neck,perineum, genitalia), andlowerfromregionsin whichpermeability is poor
medication if the medication were being
i i i i i i i i i i i i i
i i i i i i

(back, palms, soles).
applied to which of the following body areas?
i i i
i i i i i i i i


1. Back
2. Axilla
3. Soles of the feet i i i



4. Palms of the hands i i i


1. Acne
10. i10.) iThe iclinic inurse iis iperforming ian
Rationale:
i
admission assessment on a client. The nurse
i i i i i i i

Azelaicacidisatopicalmedicationusedtotreatmildtomoderateacne.Theacid
notes that the client is taking azelaic acid
i i i i i i i i i i i i i i
i i i i i i i i

appears to work by suppressing the growth of Propionibacterium acnes and
(Azelex). Because of the medication
i i i i i i i i i i i
i i i i i

decreasingtheproliferationofkeratinocytes.Options2,3,and4areincorrect.
prescription, the nurse would suspect that the
i i i i i i i i i i i i
i i i i i i i



client is being treated for:
i i i i i



1. Acne
2. Eczema
3. Hair loss i



4. Herpes simplex i

,11. i11.) iThe ihealth icare iprovider ihas iprescribed isilver
3. "The medication will permanently stain my skin."
i i i i i i




sulfadiazine (Silvadene) for the client with a partial-
i i i i i i i i
Rationale:
i




thickness burn, which has cultured positive for gram-
i i i i i i i i
Silver sulfadiazine (Silvadene) is an antibacterial that has a broad spectrum
i i i i i i i i i i




negative bacteria. The nurse is reinforcing
i i i i i i
ofactivityagainstgram-negativebacteria,gram-positivebacteria,and
i i i i i i




information to the client about the medication. Which
i i i i i i i i
yeast.Itisapplieddirectlytothewoundtoassistinhealing.Itdoesnot stain
i i i i i i i i i i i i i i i i



the skin.
statement made by the client indicates a lack of
i i
i i i i i i i i i



understanding about the treatments?
i i i i


1. "The medication is an antibacterial."
i i i i



2. "The medication will help heal the burn."
i i i i i i



3. "The medication will permanently stain my skin."
i i i i i i



4. "The medication should be applied directly to the
i i i i i i i



wound."
i



1. Notifytheregisterednurse.
12. i12.) iA inurse iis icaring ifor ia iclient iwho iis ireceiving ian
i i i



Rationale:
intravenous (IV) infusion of an antineoplastic
i
i i i i i i

When antineoplastic medications (Chemotheraputic Agents) are
medication. During theinfusion, the client complains of
i i i i i
i i i i i i i

administeredviaIV,greatcaremustbetakentopreventthemedicationfrom
pain at the insertion site. During an inspection of the
i i i i i i i i i
i i i i i i i i i i

escapingintothetissues surroundingtheinjection site, becausepain, tissue
site, the nurse notes redness and swelling and that
i i i i i i i i i i i
i i i i i i i i i

damage, and necrosis can result. The nurse monitors for signs of
the rate of infusion of the medication has slowed.
i i i i i i i i i i i
i i i i i i i i i

extravasation, such as redness or swelling at the insertion site and a
The nurse should take which appropriate action?
i i i i i i i i i i i i
i i i i i i i


1. Notify the registered nurse. i i i
decreasedinfusionrate.Ifextravasationoccurs,theregisterednurseneeds
i i i i i i



tobenotified;heorshewill thencontactthehealthcareprovider.
2. Administer painmedicationtoreduce the
i i i i i i i i i i i i i
i i


discomfort.
i



3. Apply ice and maintain the infusion rate, as
i i i i i i i



prescribed.
i



4. Elevate the extremity of the IV site, and slow the i i i i i i i i i



infusion.
i




13. i13.) iThe iclient iwith isquamous icell icarcinomaiof ithe
4. Pulmonary function studies
larynx is receiving bleomycin intravenously. The
i i
i i i i i i

Rationale:
nurse caring for the client anticipates that which
i
i i i i i i i i



diagnostic study will be prescribed?
i i i i i
Bleomycinisanantineoplasticmedication(ChemotheraputicAgents)that can
i i i i i i


cause interstitial pneumonitis, which can progress to pulmonary fibrosis.
1. Echocardiography
i i i i i i i i i



Pulmonaryfunctionstudiesalongwithhematological,hepatic,andrenal
2. Electrocardiography
i i i i i i i i i


function tests need to be monitored. The nurse needs to monitor lung
3. Cervical radiography
i i i i i i i i i i i i
i

soundsfordyspneaandcrackles,whichindicatepulmonarytoxicity.The
4. Pulmonary function studies
i i i i i i i i i i
i i

medication needs to be discontinued immediately if pulmonary toxicity
i i i i i i i i i



occurs. Options 1, 2, and 3 are unrelated to the specific use of this
i i i i i i i i i i i i i i


medication.
i


14. i14.) iThe iclient iwith iacute imyelocytic ileukemia iis ibeing
2. Uric acidlevel
treated with busulfan (Myleran). Which laboratory
i
i i i i i i

Rationale:
value would the nurse specifically monitor during
i
i i i i i i i

Busulfan (Myleran) can cause an increase in the uric acid level.
treatment with this medication?
i i i i i i i i i i
i i i i

Hyperuricemiacanproduceuricacidnephropathy,renalstones, andacute renal
1. Clotting time
i i i i
i

failure. Options 1, 3, and 4 are not specifically related to this medication.
2. Uric acid level
i i i i i i i i i i i i i
i i



3. Potassium level i



4. Blood glucose level i i

, 15. i15.) iThe iclient iwith ismall icell ilung icancer iis
4. Orthostatic hypotension Rationale:
i i i




being treated with etoposide (VePesid). The
i i i i i i
Asideeffectspecifictoetoposideisorthostatichypotension.Theclient'sblood
i i i i i i i i i i




nurse who is assisting in caring for the client
i i i i i i i i i
pressureismonitoredduringtheinfusion.Hairlossoccurswithnearlyallthe
i i i i i i i i i i i i i




during its administration understands that which
i i i i i i
antineoplastic medications. Chest pain and pulmonary fibrosis are unrelated to this
i i i i i i i i i i i




side effect is specifically associated with this
i i i i i i i
medication.
i




medication?
i


1. Alopecia
2. Chest pain i



3. Pulmonary fibrosis i



4. Orthostatic hypotension i 3. Consult with health care providers (HCPs) before receiving immunizations
i i i i i i i i i




16. i16.) iThe i clinic i nurse iis ireviewing ia i teaching iplan ifor
Rationale:
i




the client receiving an antineoplastic
i i i i i
Becauseantineoplastic medications lower theresistanceofthebody, clients must
i i i i i i i i i i




medication. When implementing the plan, the
i i i i i i
beinformednottoreceiveimmunizationswithoutaHCP'sapproval.Clientsalso
i i i i i i i i i i i




nurse tells the client:
i i i i
need to avoid contact with individuals who have recently received a live virus
i i i i i i i i i i i i i



vaccine. Clients need to avoid aspirin and aspirin-containing products to minimize the
1. To take aspirin (acetylsalicylic acid) as
i i i i i i i i i i i i
i i i i i


needed for headache
i i i
risk of bleeding, and they need to avoid alcohol to minimize the risk of toxicity
i i i i i i i i i i i i i i i




2. Drink beverages containing alcohol in
i i i i
and side effects.
i i i




moderate amounts each evening
i i i i


3. Consult with health care providers (HCPs) i i i i i



before receiving immunizations
i i i



4. That it is not necessary to consult HCPs
i i i i i i i



before receiving a flu vaccine at the local
i i i i i i i i



health fair
i i 4. Numbnessandtinglinginthefingersandtoes Rationale:
i i i i i i i i



A side effect specific to vincristine is peripheral neuropathy, which occurs in
17. i17.) iThe iclient iwith iovarian icancer iis ibeing
i i i i i i i i i i i


almosteveryclient.Peripheralneuropathycanbemanifestedasnumbnessand
treated with vincristine (Oncovin). The nurse
i i i i i i i i i i i
i i i i i i

tinglinginthefingersandtoes.DepressionoftheAchillestendonreflexmaybe
monitors the client, knowing that which of the
i i i i i i i i i i i i i i
i i i i i i i i

thefirstclinicalsignindicatingperipheralneuropathy.Constipationratherthan
following indicates a side effect specific to this
i i i i i i i i i i
i i i i i i i i

diarrhea is most likely to occur with this medication, although diarrhea may occur
medication?
i i i i i i i i i i i i i
i

occasionally. Hairloss occurs with nearly all theantineoplastic medications.
1. Diarrhea
i i i i i i i i i i


Chest pain is unrelated to this medication.
2. Hair loss
i i i i i i
i



3. Chest pain i



4. Numbness and tingling in the fingers and i i i i i i 1. Pancreatitis
toes
i Rationale:
i



Asparaginase (Elspar) is contraindicated if hypersensitivity exists, in pancreatitis, or if
18. i18.) iThe inurse iis ireviewing ithe ihistory iand
i i i i i i i i i i



the client has a history of pancreatitis. The medication impairs pancreatic
physical examination of a client who will be
i i i i i i i i i i i
i i i i i i i i

functionandpancreaticfunctiontestsshouldbeperformedbeforetherapybegins
receiving asparaginase (Elspar), an
i i i i i i i i i i
i i i i

andwhenaweekormorehaselapsedbetweenadministrationofthedoses.The
antineoplastic agent. The nurse consults with
i i i i i i i i i i i i i
i i i i i i

client needs to be monitored for signs of pancreatitis, which include nausea,
the registered nurse regarding the
i i i i i i i i i i i i
i i i i i

vomiting,andabdominalpain.Theconditionsnotedinoptions2,3,and4arenot
administration of the medication if which of the
i i i i i i i i i i i i i
i i i i i i i i

contraindicated with this medication.
following is documented in the client's history?
i i i i
i i i i i i i


1. Pancreatitis
2. Diabetes mellitus i



3. Myocardial infarction i



4. Chronic obstructive pulmonary disease i i i